Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsShortsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Cynda Rushton, PhD, RN, FAAN

Advertisement

Articles by Cynda Rushton, PhD, RN, FAAN

The Shoe Is on the Other Foot When the Nurse Has Cancer

ByJennifer Wenzel, PhD, RN, CCM, FAAN,Cynda Rushton, PhD, RN, FAAN
March 23rd 2017

Patients seek our intimate connection to their experiences as fellow human beings, rather than diagnoses or clinical solutions.

Advertisement

Latest Updated Articles

  • The Shoe Is on the Other Foot When the Nurse Has Cancer
    The Shoe Is on the Other Foot When the Nurse Has Cancer

    March 23rd 2017



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Gedatolisib for HR+/HER2- Advanced Breast Cancer: What Nurses Need to Know

2

FDA Approves First On-Body Injector for Multiple Myeloma Treatment

3

FDA Approves Gedatolisib for HR+/HER2- Metastatic Breast Cancer

4

FDA Grants Traditional Approval to Selpercatinib for RET-Fusion Solid Tumors

5

WHO Report: Global Cancer Cases to Double by 2050; Nurses Must Act

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us